These results indicate that PGK1 inhibition alleviates GDM-induced OS and improves pregnancy outcomes by restoring Keap1-Nrf2 signaling and mitochondrial function both in vivo and in vitro. This evidence concerns the gene NFE2L2 and gestational diabetes.